Christopher J. Kirk, President and CSO at Kezar Life Sciences, Inc. (KZR), bought 5,000 shares at $4.61 ($23K) on 2019-08-13, disclosed to the SEC on 2019-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |